BioAssets Development Corporation (aka BDC) (Acquired) is Profiled in this Database

Updated At 25 Oct, 2011

Partial description of this company

Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniation.

Start Trial Get Full Profile

There’s no risk. Start your trial today to see profiles of BioAssets Development Corporation (aka BDC) (Acquired) plus 4816 other startups.

Start Free 7 Day Trial Now

Learn More About BioAssets Development Corporation (aka BDC) (Acquired)

Technology/product details

Revenue projections

Capital raised to date

Growth strategy

CEO presentation